ADAMTS8 and central nervous system cancer: With the available series, GBM and grade III gliomas showed an overlapping range of relative expression of ADAMTS-8 (GBM 0.0001–0.45; grade III gliomas 0.05–0.3)(Figure 1), and no significant difference between grades.